Insider filing · RLAY
Sanjiv Patel
President and CEO
profile →
Relay Therapeutics, Inc.
RLAY · Healthcare · 32 filings in 24 months
ticker →
Sanjiv Patel sold $1.8M of Relay Therapeutics (RLAY)
Executed Jan 21 2025, disclosed Jan 23 2025, 2 days later.
Value, as filed
$1.8M
375,000 sh across 3 lots
Executed
Jan 21 2025
the trade date, as filed
Disclosed
Jan 23 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SPSanjiv Patel (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $980K of RLAY (48,199 sh × $20.33, as filed), executed Aug 17.
The name
RLAYHealthcare · Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sanjiv Patel in RLAY
RLAYSALE
Relay Therapeutics, Inc.
$913K48,199 sh × $18.94
Exec Sep 8
Filed Sep 9 · 4:12 PM ET RLAYSALE Relay Therapeutics, Inc. $980K
48,199 sh × $20.33
Exec Aug 17
Filed Aug 18 · 4:17 PM ET RLAYSALE Relay Therapeutics, Inc. $944K
48,199 sh × $19.58
Exec Jul 7
Filed Jul 8 · 5:08 PM ET RLAYSALE Relay Therapeutics, Inc. $338K
43,168 sh × $7.82
Exec Jan 6
Filed Jan 7 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $435K
62,073 sh × $7.00
Exec Nov 3 2025
Filed Nov 4 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $153K
42,740 sh × $3.57
Exec Jul 9 2025
Filed Jul 10 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $127K
42,769 sh × $2.97
Exec Apr 23 2025
Filed Apr 24 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $818K
215,506 sh across 2 lots
Exec Feb 11 2025
Filed Feb 13 2025 · 5:30 PM ET